LeadIQ logo
Learn more at LeadIQ.com

Insights

FDA-approved pivotal study Theraclion announced the launch of treatments for an FDA-approved pivotal study on varicose veins in the United States. This presents a significant sales opportunity to promote SONOVEIN® technology in the US market.

SONOVEIN HD release With the recent release of SONOVEIN HD in May 2022, Theraclion has introduced an upgraded version of its echotherapy robotic platform. Leveraging this new technology enhancement can be a compelling sales pitch for engaging existing and potential clients.

CE-marked robotic platforms Theraclion's CE-marked robotic platforms, SONOVEIN® for varicose veins and ECHOPULSE® for breast fibroadenoma and thyroid nodules, offer non-invasive treatment alternatives. Highlighting the effectiveness and safety of these platforms can drive sales by attracting healthcare providers seeking innovative solutions.

Developed Sonovein machine Theraclion's development and launch of the Sonovein machine demonstrate the company's commitment to advancing echotherapy technology. This achievement can be leveraged as a selling point to showcase the company's expertise and product capabilities to prospective clients.

Scalable robotic platform Theraclion is known for creating a scalable robotic platform for non-invasive echotherapy. Emphasizing the scalability and adaptability of this technology can be a strategic approach to target clients looking for flexible and efficient medical equipment solutions.

Similar companies to Theraclion

Theraclion Tech Stack

Theraclion uses 8 technology products and services including WordPress Super Cache, jQuery CDN, Unpkg, and more. Explore Theraclion's tech stack below.

  • WordPress Super Cache
    Caching
  • jQuery CDN
    Content Delivery Network
  • Unpkg
    Content Delivery Network
  • Google Font API
    Font Scripts
  • Backbone.js
    Javascript Frameworks
  • Open Graph
    Miscellaneous
  • SWFObject
    Miscellaneous
  • Popper
    Miscellaneous

Theraclion's Email Address Formats

Theraclion uses at least 1 format(s):
Theraclion Email FormatsExamplePercentage
First.Last@theraclion.comJohn.Doe@theraclion.com
49%
First.Middle@theraclion.comJohn.Michael@theraclion.com
1%
First.Last@theraclion.comJohn.Doe@theraclion.com
49%
First.Middle@theraclion.comJohn.Michael@theraclion.com
1%

Frequently Asked Questions

Where is Theraclion's headquarters located?

Minus sign iconPlus sign icon
Theraclion's main headquarters is located at 244 avenue Pierre Brossolette Malakoff, 92240 FR. The company has employees across 2 continents, including EuropeNorth America.

What is Theraclion's official website and social media links?

Minus sign iconPlus sign icon
Theraclion's official website is theraclion.com and has social profiles on LinkedIn.

How much revenue does Theraclion generate?

Minus sign iconPlus sign icon
As of September 2024, Theraclion's annual revenue reached $1.8M.

What is Theraclion's NAICS code?

Minus sign iconPlus sign icon
Theraclion's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Theraclion have currently?

Minus sign iconPlus sign icon
As of September 2024, Theraclion has approximately 35 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: M. D.Chief Scientific Officer: J. A.Chief Operating Officer: J. P.. Explore Theraclion's employee directory with LeadIQ.

What industry does Theraclion belong to?

Minus sign iconPlus sign icon
Theraclion operates in the Medical Equipment Manufacturing industry.

What technology does Theraclion use?

Minus sign iconPlus sign icon
Theraclion's tech stack includes WordPress Super CachejQuery CDNUnpkgGoogle Font APIBackbone.jsOpen GraphSWFObjectPopper.

What is Theraclion's email format?

Minus sign iconPlus sign icon
Theraclion's email format typically follows the pattern of . Find more Theraclion email formats with LeadIQ.

How much funding has Theraclion raised to date?

Minus sign iconPlus sign icon
As of September 2024, Theraclion has raised $5.4M in funding. The last funding round occurred on Mar 04, 2019 for $5.4M.

When was Theraclion founded?

Minus sign iconPlus sign icon
Theraclion was founded in 2004.
Theraclion

Theraclion

Medical Equipment ManufacturingMalakoff, France11-50 Employees

Theraclion is a French MedTech company committed to developing a non-invasive alternative to surgery through the innovative use of focused ultrasound.

High Intensity Focused Ultrasound (HIFU) does not require incisions nor an operating room, leaves no scars, and allows patients an immediate return to their daily activities. Echotherapy, as the HIFU treatment method is called, concentrates therapeutic ultrasounds to an internal focal point from outside of the body.

Theraclion has developed two CE-marked robotic platforms delivering echotherapy: SONOVEIN® for varicose veins and ECHOPULSE® for breast fibroadenoma and thyroid nodules. Each representing the potential to replace millions of surgical procedures every year.

Based in Malakoff (Paris), the Theraclion team is made up of 30 people, mainly in technological and clinical development.

Section iconCompany Overview

Headquarters
244 avenue Pierre Brossolette Malakoff, 92240 FR
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2004
Employees
11-50

Section iconFunding & Financials

  • $5.4M

    Theraclion has raised a total of $5.4M of funding over 2 rounds. Their latest funding round was raised on Mar 04, 2019 in the amount of $5.4M.

  • $10M

    Theraclion's revenue is in the range of $10M

Section iconFunding & Financials

  • $5.4M

    Theraclion has raised a total of $5.4M of funding over 2 rounds. Their latest funding round was raised on Mar 04, 2019 in the amount of $5.4M.

  • $10M

    Theraclion's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.